Top Institutions in Ophthalmology - Retinal Diseases
Leading academic medical centers and research institutions with strong ophthalmology and retinal disease programs conduct clinical trials, translational research, and drug development in anti-VEGF therapies and novel sustained-release drug delivery systems for wet AMD.
-
#1
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt is a leader in retinal disease research and clinical trials, exemplified by Dr. Avni Finn's involvement in the DAVIO2 trial investigating EYP-1901 for wet AMD, highlighting their expertise in novel therapeutic development.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its pioneering research and clinical care in retinal diseases including wet AMD, with extensive experience in anti-VEGF therapies and sustained drug delivery systems.
-
#3
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a premier center for retinal disease research, contributing significantly to the development of anti-VEGF agents and novel therapies for wet AMD through robust translational and clinical research programs.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its innovative retinal research and clinical trials in wet AMD, focusing on improving treatment efficacy and reducing injection burden through novel drug delivery methods.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a robust ophthalmology department with a focus on retinal diseases and clinical trials, contributing to advancements in wet AMD treatment including anti-VEGF and emerging sustained-release therapies.
